Over the last decade, there have been numerous developments and changes in treatment
practices for the management of patients with immune thrombocytopenia (ITP). This article is …

The MYH9 gene encodes the heavy chain of non-muscle myosin IIA, a widely expressed
cytoplasmic myosin that participates in a variety of processes requiring the generation of …

Immune thrombocytopenia (ITP) is the most common acquired thrombocytopenia after
chemotherapy-induced thrombocytopenia. Existing guidelines describe the management …

Abnormalities of platelet size are one of the distinguishing features of inherited
thrombocytopenias (ITs), and evaluation of blood films is recommended as an essential step …

Background Heritable bleeding and platelet disorders (BPD) are heterogeneous and
frequently have an unknown genetic basis. The BRIDGE-BPD study aims to discover new …

Patients with inherited thrombocytopenias often require platelet transfusions to raise their
platelet count before surgery or other invasive procedures; moreover, subjects with clinically …

MYH 9‐Related Disorders are a group of rare autosomal dominant platelet disorders
presenting as nonsyndromic forms characterized by macrothrombocytopenia with giant …

Abstract β1-Tubulin plays a major role in proplatelet formation and platelet shape
maintenance, and pathogenic variants in TUBB1 lead to thrombocytopenia and platelet …

Inherited platelet disorders (IPDs) are rare diseases featured by low platelet count and
defective platelet function. Patients have variable bleeding diathesis and sometimes …

In this issue we highlight a very topical and timely review by Noris and colleagues entitled
“New roles for MPV measurement in clinical practice?”[1], and discuss our newly proposed …